Santé log21h
Capricor Therapeutics to Present Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update on March 19
Capricor Therapeutics Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update Conference Call and Webcast A replay of the webcast will be available following the conclusion of ...
Santé log21h
Better Choice Company Signs Binding Letter of Intent to Acquire Choice Specialty Pharmacy, Expanding U.S. Presence
"With the addition of Choice Specialty Pharmacy Group alongside our SRx platform in Canada, we are now executing on our strategy to build a healthcare services company with significant market share in ...
Santé log21h
NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
Submission for New Intended Use That Leverages Company’s Patented OneRF® Technology Platform Expected in May 2025 ...
Santé log21h
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...
Santé log21h
AIM ImmunoTech Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
OCALA, Fla., March 11, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced its participation in the Virtual Investor “ Top 5 for ‘25” On-Demand ...
Santé log21h
HealthEquity Community Foundation Announces First Grant Recipients and Opens Next Funding Cycle
The HealthEquity Community Foundation’s next grant application cycle is now open. Grant submissions will be accepted through March 31. Eligible 501 (c) (3) charitable organizations are encouraged to ...
Santé log21h
GRI Bio Regains Compliance with Nasdaq’s Minimum Bid Price Rule
About GRI Bio, Inc. GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio’s therapies are ...
Santé log21h
Woodstock Sterile Solutions Invests $8 million in New Automated, High-Speed, State-of-the-Art, Bottle Packaging Line
WOODSTOCK, Ill., March 11, 2025 (GLOBE NEWSWIRE) -- Woodstock Sterile Solutions, a leading blow-fill-seal (BFS) contract development and manufacturing organization (CDMO), is expanding its BFS ...
Santé log21h
AMPS Launches ClaimInsight: A Next-Generation Payment Integrity Suite Built for Accuracy, Speed, and Value
PHOENIX, March 11, 2025 (GLOBE NEWSWIRE) -- Advanced Medical Pricing Solutions (AMPS), a leader in healthcare cost containment and payment integrity solutions, today announced the launch of ...
Santé log21h
Little Leaves Behavioral Services Expands in Maryland and Virginia
Little Leaves currently operates 14 centers across Washington, D.C., Maryland, Virginia and Florida. Each center’s highly trained clinical team delivers individualized, evidence-based applied ...
Santé log21h
Baylor Genetics to Showcase Genetic Testing Innovations for Rare Disease at ACMG 2025 Annual Clinical Genetics Meeting
At the event, Baylor Genetics will highlight its innovative testing solutions in the rare disease space with one presentation and three poster sessions: ...
Santé log21h
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering
The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation NEW YORK, March ...